Pharma Journalist - Page 667 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Thermo Fisher Scientific to invest in new Pharma Service Facility in Germany

FDA Grants Priority Review for a sNDA for XTANDI (enzalutamide) in Non-Metastatic CRPC

Ionis and Akcea Partner to Commercialize Inotersen for hATTR

Lundbeck to acquire Prexton Therapeutics

Intezyne Partners with Exosome Diagnostics on IT-139 Companion Diagnostic

Mallinckrodt Completes Sale Of RECOTHROM And PREVELEAK To Baxter

Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada

Nexcelom Bioscience announces strategic growth investment from Ampersand Capital Partners

Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin Injection

MHRA Grants UK Patients Early Access to Akcea Therapeutics’ Volanesorsen for FCS